A randomized, double‐blind, single‐dose, three‐arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris®) in healthy male subjects - Chow, Vincent; Pan, Jean; Chien, David; Mytych, Daniel T.; Hanes, Vladimir (European journal of haematology, 2020)
Keywords: ABP 959; biosimilar; Complement component C5; Double-blind studies; eculizumab; Immunogenicity; Monoclonal antibodies; Original; paroxysmal nocturnal hemoglobinuria; Pharmacodynamics; Pharmacokinetics; United States--US; paroxysmal nocturnal hemoglobinuria; eculizumab; ABP 959; biosimilar